Cervical Cancer (cont.)
Medical Author:
Melissa Conrad Stöppler, MD, Chief Medical Editor
Melissa Conrad Stöppler, MD, Chief Medical EditorMelissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology. Medical Editor:
Jerry R. Balentine, DO, FACEP
Jerry R. Balentine, DO, FACEPDr. Balentine received his undergraduate degree from McDaniel College in Westminster, Maryland. He attended medical school at the Philadelphia College of Osteopathic Medicine graduating in1983. He completed his internship at St. Joseph's Hospital in Philadelphia and his Emergency Medicine residency at Lincoln Medical and Mental Health Center in the Bronx, where he served as chief resident. IN THIS ARTICLE
Cervical Cancer PreventionThe key to preventing invasive cervical cancer is to detect any cell changes early, before they become cancerous. Regular pelvic examinations and Pap smears are the best way to do this. How often a woman should have a pelvic exam and Pap smear depends on her individual situation.
Avoidance of human papillomavirus (HPV) infection is becoming increasingly important in the prevention of precancerous and cancerous changes of the cervix.
Two vaccines have been approved for the prevention of HPV infection. Both vaccines are given in three doses over a six-month period. Gardasil is a vaccine that targets four different types of HPV. It is approved for use in females for the prevention of cervical cancer, and some vulvar and vaginal cancers, caused by HPV types 16 and 18, and for use in males and females for the prevention of anal cancer and precancerous anal lesions caused by HPV types 16 and 18. Gardasil is also approved for the prevention of genital warts caused by HPV types 6 and 11. The vaccine is approved for these uses in females and males ages 9 to 26. The Cervarix vaccine targets two HPV types: 16 and 18, which are the types associated with the majority of cervical cancers. The FDA has approved Cervarix for use in females aged 9 to 25 for the prevention of cervical cancer caused by HPV types 16 and 18. Cigarette smoking is another risk factor for cervical cancer that can be prevented. Quitting smoking may decrease your chances of developing cervical cancer. Next Page: Must Read Articles Related to Cervical Cancer
Cancer Symptoms
Most symptoms and signs of cancer may also be explained by harmless conditions, so it's important to limit one's risk factors and undergo appropriate cancer scr...learn more >>
Cancer: What You Need to Know
The news comes like a sledgehammer into the stomach: "I'm sorry to tell you, but you have cancer." Every year, a million Americans are devastated by news of can...learn more >>
Cervical Dysplasia
Cervical dysplasia is the presence of precancerous changes in the cells of the lining of the cervix. Cervical dysplasia is classified by two terms, squamous int...learn more >>
Viewer Comments & ReviewsCervical Cancer - Risk FactorsThe eMedicineHealth physician editors ask:Did you have any of the risk factors for cervical cancer at the time of your diagnosis? If so, what were they? |
Women's Health
Find out what women really need.
From WebMD
Cancer Resources
Featured Centers
Health Solutions From Our Sponsors
Read What Your Physician is Reading on Medscape
Cervical Cancer »
Cervical cancer is the second most common malignancy in women worldwide, and it remains a leading cause of cancer-related death for women in developing countries.
Featured Topics
Medical Dictionary
Pill Identifier on RxList
- quick, easy,
pill identification
Find a Local Pharmacy
- including 24 hour, pharmacies




